Leukaemia Foundation celebrates National Volunteer Week 2019
- Media releases
- Our supporters
Month: May 2019
Australian study first ever to use CAR T-cells to prevent relapse after treatment
In a world first, the Australian COMMITTAL trial uses CAR T-cell therapy to improve survival for people with B-cell ALL who have an allogeneic stem cell transplant.
- Acute lymphoblastic leukaemia
- Research
- Treatments and side-effects
Leukaemia Foundation supports Labor’s $20 million blood cancer Right to Trial
- Advocacy and policy
- Clinical trials
- Media releases
New score to help navigate improved treatment for follicular lymphoma patients
- Media releases
- Non-Hodgkin lymphoma
Leukaemia Foundation supports Australian Research Innovation
- Media releases
- Research
May is Myeloma Awareness Month
- Media releases
- Myeloma
Welcome commitment to reduce out-of-pocket cancer costs
- Advocacy and policy
- Media releases
Labor’s commitment to blood cancer
The Leukaemia Foundation welcomes Federal Labor’s commitment of $20 million to give Australian blood cancer patients faster access to leading clinical trial drugs and therapies through a new Right to Trial program.
- Advocacy and policy
- Hon. Anna Bligh AC Joins Leukaemia Foundation as National Ambassador
- Talking Blood Cancer: Mother-Daughter Cancer Warriors
- The biggest challenge of cancer patients that nobody talks about…
- Physiotherapist and lymphoma survivor Julie Allen on cancer related fatigue
- Unlocking the Mysteries of Blood Cancer